Healthtech startup with an AI decision-making engine for clinical trial design and planning.
| Date | Round | Amount |
|---|---|---|
| Feb 2026 | Series A Biorce (Barcelona) closed a $52 million Series A led by DST Global Partners, the largest Iberian healthtech/AI Series A, six months after its previous round. | $52M |
| Jul 2025 | Series A Biorce raised €5M from Norrsken VC, bringing total funding to €8.5M, to accelerate US expansion of its AI clinical-trial platform. | $5.8M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.